Obovatols, new chitin synthase 2 inhibitors of Saccharomyces cerevisiae from Magnolia obovata

Cited 29 time in scopus
Metadata Downloads
Obovatols, new chitin synthase 2 inhibitors of Saccharomyces cerevisiae from Magnolia obovata
Eui Il Hwang; Byoung-Mog Kwon; Seoung Ho Lee; Na Rae kim; Tae Hoon Kang; Young Tae Kim; Byoung Keun Park; Sung Uk Kim
Bibliographic Citation
Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 95-101
Publication Year
In the course of the search for inhibitors of ScCHS2 from natural sources, we have isolated a new type of chitin synthase 2 inhibitor, obovatol, which has a biphenol skeleton, from Magnolia obovata. Obovatol inhibited chitin synthase 2 activity of Saccharomyces cerevisiae with an IC50 of 38 μM. Its derivative, tetrahydroobovatol, inhibited chitin synthase 2 activity under the same conditions with an IC50 of 59 μM. These compounds exhibited no inhibitory activity for ScCHS3, and showed less inhibitory activity for chitin synthase 1 than for chitin synthase 2 (IC50 > 1 mM). These results indicated that obovatol and tetrahydroobovatol are specific inhibitors of ScCHS2. They also inhibited CaCHS1, which is structurally and functionally analogous to ScCHS2, with similar IC50s to ScCHS2 (IC50 28 and 51 μM, respectively). The compounds exhibited mixed competitive inhibition with respect to UDP-N-acetyl-D-glucosamine as substrate [inhibition constant (Ki) 21.8 μM for obovatol and 23.1 μM for tetrahydroobovatol]. Furthermore, they showed antifungal activities against various pathogenic fungi, with a particularly strong inhibitory activity against Cryptococcus neoformans (MIC 7.8 mg/L). The results indicate that obovatol and tetrahydroobovatol can potentially serve as antifungal agents.
chitin synthasetransferase inhibitorsaccharomyces cerevisiaechitin synthaseenzyme inhibitorsmagnoliaceae
Oxford Univ Press
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.